Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Assets (2016 - 2025)

Historic Assets for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $353.1 million.

  • Anaptysbio's Assets fell 2843.84% to $353.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.1 million, marking a year-over-year decrease of 2843.84%. This contributed to the annual value of $483.8 million for FY2024, which is 695.09% up from last year.
  • Anaptysbio's Assets amounted to $353.1 million in Q3 2025, which was down 2843.84% from $335.2 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Assets registered a high of $643.1 million during Q4 2021, and its lowest value of $335.2 million during Q2 2025.
  • Its 5-year average for Assets is $488.3 million, with a median of $483.8 million in 2024.
  • Its Assets has fluctuated over the past 5 years, first surged by 5770.5% in 2022, then crashed by 2843.84% in 2025.
  • Over the past 5 years, Anaptysbio's Assets (Quarter) stood at $643.1 million in 2021, then fell by 5.08% to $610.4 million in 2022, then decreased by 25.88% to $452.4 million in 2023, then grew by 6.95% to $483.8 million in 2024, then dropped by 27.02% to $353.1 million in 2025.
  • Its last three reported values are $353.1 million in Q3 2025, $335.2 million for Q2 2025, and $422.1 million during Q1 2025.